SiteOne Therapeutics Garners $1,500,000 New Funding

  • Feed Type
  • Date
  • Company Name
    SiteOne Therapeutics
  • Mailing Address
    953 Indiana Street San Francisco, CA 94107 USA
  • Company Description
    SiteOne Therapeutics, located in San Francisco, is developing novel therapeutics and diagnostics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes will be used to advance its oral Na?1.7 inhibitor program for pain and to further develop its technology platform for long-acting local analgesics, pain diagnostics and other pain indications.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy